Federated Hermes, Inc. Bio Xcel Therapeutics, Inc. Transaction History
Federated Hermes, Inc.
- $43 Billion
- Q4 2024
A detailed history of Federated Hermes, Inc. transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 4,819 shares of BTAI stock, worth $16,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,819
Previous 4,819
-0.0%
Holding current value
$16,240
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BTAI
# of Institutions
52Shares Held
8.63MCall Options Held
34.5KPut Options Held
59.4K-
Armistice Capital, LLC New York, NY4.32MShares$14.5 Million0.02% of portfolio
-
Ubs Group Ag1.28MShares$4.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$1.49 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$1.05 Million0.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $94.4M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...